<DOC>
	<DOCNO>NCT01510717</DOCNO>
	<brief_summary>The purpose study compare safety efficacy investigational multifocal intraocular lens ( IOL ) FDA-approved monofocal IOL .</brief_summary>
	<brief_title>Clinical Investigation AcrySof® IQ ReSTOR® +2.5 D Multifocal Intraocular Lens ( IOL ) Model SN6AD2 SV25T0</brief_title>
	<detailed_description>Participants 21 year old need cataract extraction consent randomized 1:1 ratio investigative site receive either AcrySof® IQ ReSTOR® +2.5 D Multifocal IOL Model SN6AD2 [ SV25T0 ] AcrySof® IQ Monofocal IOL Model SN60WF eye . Each participant complete preoperative examination eye , implantation IOL operative visit eye , 7 postoperative visit , monocular test Day 1-2 , Day 7-14 , Day 30-60 , monocular binocular test Day 120-180 follow second implantation . The first eye implant consider primary eye . The second eye implant 7 30 day first . If first eye implant surgery , second eye eligible . If second eye implant surgery , first eye follow .</detailed_description>
	<mesh_term>Cataract</mesh_term>
	<criteria>Diagnosis bilateral cataract Willing able complete require postoperative visit Calculated lens power within available supply range Planned cataract removal phacoemulsification Potential postoperative visual acuity 0.2 logMAR well eye Preoperative astigmatism le 1.0 diopter Clear intraocular medium cataract study eye Preoperative Best Corrected Distance Visual Acuity ( BCDVA ) worse 0.2 logMAR Able undergo second eye surgery 7 day 30 day first eye surgery Other protocoldefined inclusion criterion may apply Previous refractive surgery Inflammation edema cornea Optic nerve atrophy Pregnancy Current participation another investigational drug device study Other protocoldefined exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Intraocular Lens</keyword>
	<keyword>Monofocal</keyword>
	<keyword>Multifocal</keyword>
</DOC>